NEW YORK--(BUSINESS WIRE)--Rosen Law Firm, a global investor rights law firm, reminds investors that a shareholder filed a class action on behalf of all purchasers of securities of Gritstone bio, Inc.
Gritstone bio (NASDAQ:GRTS) stock fell 10% in post-market trading Monday after the company announced interim Phase 2 data for its Granite immunotherapy in the treatment of colorectal cancer and that ...
Gritstone bio (NASDAQ:GRTS) has filed for Chapter 11 bankruptcy protection in Delaware, according to a court filing. The California-based biotech intends to use the court-administered restructuring ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results